274 related articles for article (PubMed ID: 19850156)
21. Surveillance of patients with long-segment Barrett's esophagus: A multicenter prospective cohort study in Japan.
Matsuhashi N; Sakai E; Ohata K; Ishimura N; Fujisaki J; Shimizu T; Iijima K; Koike T; Endo T; Kikuchi T; Inayoshi T; Amano Y; Furuta T; Haruma K; Kinoshita Y
J Gastroenterol Hepatol; 2017 Feb; 32(2):409-414. PubMed ID: 27416773
[TBL] [Abstract][Full Text] [Related]
22. Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.
Thota PN; Vennalaganti P; Vennelaganti S; Young P; Gaddam S; Gupta N; Lieberman D; Sampliner R; Falk GW; Mathur S; Kennedy K; Cash BD; Moawad F; Bansal A; Spaander MC; Bruno MJ; Vargo J; Sharma P
Gastroenterology; 2017 Apr; 152(5):987-992. PubMed ID: 27988383
[TBL] [Abstract][Full Text] [Related]
23. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
24. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
25. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
26. Risk of neoplastic progression in Barrett's esophagus diagnosed as indefinite for dysplasia: a nationwide cohort study.
Kestens C; Leenders M; Offerhaus GJ; van Baal JW; Siersema PD
Endoscopy; 2015 May; 47(5):409-14. PubMed ID: 25521571
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
28. Mortality in Barrett's esophagus: three decades of experience at a single center.
Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Bardhan KD
Endoscopy; 2012 Oct; 44(10):892-8. PubMed ID: 22752886
[TBL] [Abstract][Full Text] [Related]
29. Clinical and histologic determinants of mortality for patients with Barrett's esophagus-related T1 esophageal adenocarcinoma.
Leggett CL; Lewis JT; Wu TT; Schleck CD; Zinsmeister AR; Dunagan KT; Lutzke LS; Wang KK; Iyer PG
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):658-64.e1-3. PubMed ID: 25151255
[TBL] [Abstract][Full Text] [Related]
30. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis.
Rastogi A; Puli S; El-Serag HB; Bansal A; Wani S; Sharma P
Gastrointest Endosc; 2008 Mar; 67(3):394-8. PubMed ID: 18045592
[TBL] [Abstract][Full Text] [Related]
31. Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening.
Yang Y; Chen HN; Wang R; Tang YJ; Chen XZ
Medicine (Baltimore); 2015 Sep; 94(39):e1105. PubMed ID: 26426603
[TBL] [Abstract][Full Text] [Related]
32. Surveillance in Patients With Barrett's Esophagus for Early Detection of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Qiao Y; Hyder A; Bae SJ; Zarin W; O'Neill TJ; Marcon NE; Stein L; Thein HH
Clin Transl Gastroenterol; 2015 Dec; 6(12):e131. PubMed ID: 26658838
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
34. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival.
Tramontano AC; Sheehan DF; Yeh JM; Kong CY; Dowling EC; Rubenstein JH; Abrams JA; Inadomi JM; Schrag D; Hur C
Am J Gastroenterol; 2017 Aug; 112(8):1256-1264. PubMed ID: 28374815
[TBL] [Abstract][Full Text] [Related]
35. An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.
Kroep S; Lansdorp-Vogelaar I; Rubenstein JH; de Koning HJ; Meester R; Inadomi JM; van Ballegooijen M
Gastroenterology; 2015 Sep; 149(3):577-85.e4; quiz e14-5. PubMed ID: 25935635
[TBL] [Abstract][Full Text] [Related]
36. Total cancer incidence and overall mortality are not increased among patients with Barrett's esophagus.
Schouten LJ; Steevens J; Huysentruyt CJ; Coffeng CE; Keulemans YC; van Leeuwen FE; Driessen AL; van den Brandt PA
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):754-61. PubMed ID: 21570484
[TBL] [Abstract][Full Text] [Related]
37. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
[TBL] [Abstract][Full Text] [Related]
38. Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.
Hu Q; Sun TT; Hong J; Fang JY; Xiong H; Meltzer SJ
PLoS One; 2017; 12(1):e0169691. PubMed ID: 28072858
[TBL] [Abstract][Full Text] [Related]
39. Meta analysis: Cancer risk in Barrett's oesophagus.
Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis.
Zhang S; Zhang XQ; Ding XW; Yang RK; Huang SL; Kastelein F; Bruno M; Yu XJ; Zhou D; Zou XP
Br J Cancer; 2014 Apr; 110(9):2378-88. PubMed ID: 24651385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
